SGC-NSP2hel-1
SGC-NSP2hel-1 (RA-0188293), a chemical probe, is a potent, specific and orally active nsP2 inhibitor. SGC-NSP2hel-1 has broad spectrum activity against multiple alphaviruses of the nsP2 helicase with a CC50 > 250 μM. SGC-NSP2hel-1 (RA-0188293) shows selectivity index > 4000 against human RNA helicases. SGC-NSP2hel-1 reduces virus replication and limited virus-induced pathology by forming a stable complex with nsP2 and ATP in a preclinical small animal model of CHIKV disease[1].
Product Specifications
Product Name Alternative
RA-0188293; RA-NSP2-1
UNSPSC
12352005
Target
Flavivirus; Virus Protease
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
O=C(C1(CCCC1)C2=CC=CC=C2)N(CC3)CCC43OCC[C@@H](CN5CCCCS5(=O)=O)C4
Molecular Formula
C26H38N2O4S
Molecular Weight
474.66
References & Citations
[1]John D. Sears, et al. Identification of a Broadly Acting Inhibitor of the Alphavirus Non-Structural Protein 2 Helicase. bioRxiv.June 04,2025.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
MyoD1 (Rhabdomyosarcoma Marker) (MYOD1/2075R), CF647 conjugate, 0.1mg/mL
